Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fournier Gangrene: A Disproportionality Analysis Using the Japanese Adverse Drug Event Report Database. (PubMed, Am J Ther) - Sep 10, 2026 - "All 5 SGLT2 inhibitors were associated with FG, with empagliflozin carrying the highest risk. Male patients exhibited elevated susceptibility. Continuous monitoring throughout treatment is essential. Further clinical trials are warranted to clarify causal relationships."
Adverse events • Journal • Genetic Disorders • Obesity
|
|
Aiping Wang; Gai Li; Guangyuan Xiang; Haitao Zhang; Jin'an Chen; Lei Wang; Leilei Dong; Liyi Li; Tianyuan Wang; Xinjuan Sun
|